RB..L Share News (RB.)
RB. Share
RB. Share
RB. Share
RB. Share
RB.
RB. Share
RB. Broker
RB. Directors
RB. Financial
RB.
RB. Short
RB.Fri, 24th Apr 2020 11:18
April 24 (Reuters) - Lysol and Dettol maker Reckitt
Benckiser said on Friday its disinfectants should not be
administered to humans, after U.S. President Donald Trump said
researchers should try putting disinfectant into coronavirus
patients' bodies.
"Under no circumstance should our disinfectant products be
administered into the human body (through injection, ingestion
or any other route)," the company said.
(Reporting by Tanishaa Nadkar in Bengaluru; editing by Patrick
Graham)
UK BROKER RATINGS SUMMARY: Jefferies Cuts Balfour Beatty To Hold
Read moreLONDON, June 29 (Reuters) - British drugmaker Indivior said on Monday it had appointed Mark Crossley as chief executive to replace Shaun Thaxter, who had stepped down in mutual agreement with the board.Crossley has been chief financial officer of ...
Read more(For a live blog on European stocks, type LIVE/ in an Eikon news window)* BAT, Unilever, Tesco biggest boost to FTSE 100* Pound slides on EU trade deal doubts* Aston Martin slumps on weak outlook, stock offering* FTSE 100 up 0.2%, FTSE 250 up 0.01% ...
Read moreUK BROKER RATINGS SUMMARY: JPMorgan Raises Rentokil Initial And Bunzl
Read more
(Sharecast News) - Scapa Group: Berenberg reiterates buy with a target price of 150p.
Read moreUK BROKER RATINGS SUMMARY: Berenberg Likes Direct Line And Hastings
Read moreUK BROKER RATINGS SUMMARY: Berenberg Cuts Big Yellow To Hold From Buy
Read moreUK BROKER RATINGS SUMMARY: Morgan Stanley Upgrades Smith & Nephew
Read more(Adds interview with researcher)LONDON, June 3 (Reuters) - British doctors are trialling a formulation of anti-inflammatory ibuprofen to see if it reduces respiratory failure in patients with severe symptoms of COVID-19.The trial involves a partic...
Read moreLONDON, June 3 (Reuters) - British doctors are trialling a formulation of anti-inflammatory ibuprofen to see if it reduces respiratory failure in patients with severe symptoms of COVID-19.The trial involves a particular formulation of ibuprofen, ...
Read moreUK BROKER RATINGS SUMMARY: Barclays Lowers Admiral, Raises Direct Line
Read moreReckitt Benckiser Non-Executive Director Steps Down After Ten Years
Read moreMoody's Assigns A3 To New Reckitt Benckiser Notes, Outlook Negative
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read more(Sharecast News) - Go-Ahead Group: Canaccord upgrades to buy with a target price of 1,650p.
Read more